Botanical species · safety record

Physalis peruviana

The EFSA Compendium of Botanicals holds 26 constituent measurements and 3 adverse-effect records for Physalis peruviana. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Physalis peruviana L.

26Constituent measurements
3Safety records
12Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Withanolides9
  • Tropane alkaloids3
  • Physoperuvine2
  • 1,8-cineole1
  • 3alpha-tigloyloxytropane1
  • Alkaloids1
  • Benzaldehyde1
  • Cardiac glycosides1
  • Cuscohygrine1
  • Hygrine1

Plant parts

  • Fruit unspecified9
  • Roots and other underground parts8
  • Aerial part of plants7
  • Leaves3
  • Live plants1
  • Unspecified1

Preparations

  • Solvent extraction17
  • Raw, no heat treatment6
  • Powder2

Effect types

  • Systemic2
  • None1

Target tissues

  • Urogenital: kidneys2
  • Heart1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-cineoleFruit unspecified0.093 Microgram/100 gramGC-MSResolve DOI
3alpha-tigloyloxytropaneRoots and other underground partsSolvent extractionGC-MSResolve DOI
AlkaloidsFruit unspecifiedRaw, no heat treatment1.31 Milligram/100 gramUnspecifiedResolve DOI
BenzaldehydeFruit unspecified58.5 Microgram/100 gramGC-MSResolve DOI
Cardiac glycosidesFruit unspecifiedRaw, no heat treatmentColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
CuscohygrineRoots and other underground partsSolvent extractionGC-MSResolve DOI
HygrineRoots and other underground partsSolvent extractionGC-MSResolve DOI
MyrceneFruit unspecified6.2 Microgram/100 gramGC-MSResolve DOI
PhygrineAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
PhysoperuvineRoots and other underground partsSolvent extractionGC-MSResolve DOI
SaponinsFruit unspecifiedRaw, no heat treatmentColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Steroidal saponinsLeavesSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Tropane alkaloidsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Tropane alkaloidsRoots and other underground partsSolvent extractionGC-MSResolve DOI
Tropane alkaloidsRoots and other underground partsSolvent extractionGC-MSResolve DOI
TropineRoots and other underground partsSolvent extractionGC-MSResolve DOI
WithanolidesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
WithanolidesUnspecifiedUnspecifiedResolve DOI
WithanolidesAerial part of plantsSolvent extraction2.2 MilligramStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
WithanolidesFruit unspecifiedRaw, no heat treatment7.69 Milligram/100 gramUnspecifiedResolve DOI
WithanolidesAerial part of plantsSolvent extraction1.6 MilligramStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
WithanolidesAerial part of plantsSolvent extraction2.9 MilligramStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
WithanolidesAerial part of plantsSolvent extraction6.9 MilligramStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
WithanolidesFruit unspecifiedRaw, no heat treatment5.86 Milligram/100 gramUnspecifiedResolve DOI
PhysoperuvineRoots and other underground partsSolvent extractionUnspecifiedNo resolvable identifier
WithanolidesLive plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NoneUrogenital: kidneysLeavesPowderGuinea pig (as animal)Acute toxicityResolve DOI
SystemicUrogenital: kidneysLeavesPowderGuinea pig (as animal)Acute toxicityResolve DOI
SystemicHeartFruit unspecifiedRaw, no heat treatmentRat (as animal)SubchronicResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Xu, Ya-Ming., Wijeratne, E. M. Kithsiri., Babyak, Ashley L., Marks, Hanna R., Brooks, Alan D., Tewary, Poonam., Xuan, Li-Jiang., Wang, Wen-Qiong., Sayers, Thomas J., Gunatilaka, A. A. Leslie. Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells . Journal of natural products, 2017, vol. 80, no. 7, p. 1981-1991. DOI
  2. KUBWABO, C., ROLLMANN, B., TILQUIN, B. ANALYSIS OF ALKALOIDS FROM PHYSALIS-PERUVIANA BY CAPILLARY GC, CAPILLARY GC-MS, AND GC-FTIR . Planta medica, 1993, vol. 59, no. 2, p. 161-163. DOI
  3. Kasali, Felicien Mushagalusa., Kadima, Justin Ntokamunda., Mpiana, Pius Tshimankinda., Ngbolua, Koto-te-Nyiwa., Tshibangu, Damien Sha-Tshibey. Assessment of antidiabetic activity and acute toxicity of leaf extracts from Physalis peruviana L. in guinea-pig . Asian pacific journal of tropical biomedicine, 2013, vol. 3, no. 11, p. 841-846. DOI
  4. Ahmad, S., Yasmin, R., Malik, A. New withanolide glycosides from Physalis peruviana L.. Chemical & pharmaceutical bulletin, 1999, vol. 47, no. 4, p. 477-480.
  5. Lee, Chien-Chin., Chang, Wen-Hsin., Chang, Ya-Sian., Liu, Ting-Yuan., Chen, Yu-Chia., Wu, Yang-Chang., Chang, Jan-Gowth. 4 beta-Hydroxywithanolide E Modulates Alternative Splicing of Apoptotic Genes in Human Hepatocellular Carcinoma Huh-7 Cells . Scientific reports, 2017, vol. 7. DOI
  6. Henrich, C. J., Brooks, A. D., Erickson, K. L., Thomas, C. L., Bokesch, H. R., Tewary, P., Thompson, C. R., Pompei, R. J., Gustafson, K. R., McMahon, J. B., Sayers, T. J. Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation . Cell death & disease, 2015, vol. 6. DOI
  7. El-Gengaihi, Souad E., Hamed, Manal A., Khalaf-Allah, Abd El-Rahman M., Mohammed, Mona A. Golden Berry Juice Attenuates the Severity of Hepatorenal Injury. Journal of dietary supplements, 2013, vol. 10, no. 4, p. 357-369. DOI
  8. Perk, Basak Ozlem., Ilgin, Sinem., Atli, Ozlem., Duymus, Hale Gamze., Sirmagul, Basar. Acute and Subchronic Toxic Effects of the Fruits of Physalis peruviana L. . Evidence-based complementary and alternative medicine, 2013. DOI
  9. BASEY, K., MCGAW, BA., WOOLLEY, JG. PHYGRINE, AN ALKALOID FROM PHYSALIS SPECIES. Phytochemistry, 1992, vol. 31, no. 12, p. 4173-4176. DOI
  10. Arun, M., Asha, V. V. Preliminary studies on antihepatotoxic effect of Physalis peruviana Linn. (Solanaceae) against carbon tetrachloride induced acute liver injury in rats . Journal of ethnopharmacology, 2007, vol. 111, no. 1, p. 110-114. DOI
  11. Ray, Anil B., Sahai, Mahendra., Sethi, Prabhu D. Physoperuvine, a new alkaloid of Physalis peruviana Linn. Chemistry & industry (london, united kingdom), 1976, vol. (10), p. 454-5.
  12. Kupska, Magdalena., Jelen, Henryk H. In-tube extraction for the determination of the main volatile compounds in Physalis peruviana L . Journal of separation science, 2017, vol. 40, no. 2, p. 532-541. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue